Compared with tendon tissues from other groups, repaired tendons from the TSC group (treated with EUG-BMSC-EVs) exhibited a higher level of bFGF (Figures 8(a) and 8(b)). This evidence concerns the gene FGF2 and tuberous sclerosis.